113 related articles for article (PubMed ID: 35044417)
1. Treatment of Progressive Nodular Histiocytosis With Baricitinib.
Huang Y; Zhang Z; Zhu L; Chen Y
JAMA Dermatol; 2022 Mar; 158(3):325-327. PubMed ID: 35044417
[No Abstract] [Full Text] [Related]
2. Inhibition of Progression of Acrodermatitis Continua of Hallopeau With Baricitinib.
Han GM; Yang WS; Yang B
JAMA Dermatol; 2021 Apr; 157(4):466-468. PubMed ID: 33656520
[No Abstract] [Full Text] [Related]
3. Baricitinib: A chance to treat COVID-19?
Lo Caputo S; Corso G; Clerici M; Santantonio TA
J Med Virol; 2020 Nov; 92(11):2343-2344. PubMed ID: 32437019
[No Abstract] [Full Text] [Related]
4. Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis.
Delvino P; Bartoletti A; Monti S; Biglia A; Montecucco C; Carducci M; Ripamonti G; Cavagna L
Rheumatology (Oxford); 2020 Dec; 59(12):e125-e127. PubMed ID: 32353871
[No Abstract] [Full Text] [Related]
5. Successful treatment of spondyloenchondrodysplasia with baricitinib.
Shimizu M; Inoue N; Mizuta M; Irabu H; Okajima M; Honda Y; Nihira H; Izawa K; Yachie A; Wada T
Rheumatology (Oxford); 2021 Feb; 60(2):e44-e46. PubMed ID: 32856090
[No Abstract] [Full Text] [Related]
6. Repigmentation of vitiligo with oral baricitinib.
Mumford BP; Gibson A; Chong AH
Australas J Dermatol; 2020 Nov; 61(4):374-376. PubMed ID: 32491188
[No Abstract] [Full Text] [Related]
7. Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report.
Valor-Méndez L; Voskens C; Rech J; Kleyer A; Schett G
Rheumatology (Oxford); 2021 Apr; 60(4):e122-e123. PubMed ID: 33141876
[No Abstract] [Full Text] [Related]
8. Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib.
De Stefano L; Bobbio-Pallavicini F; Montecucco C; Bugatti S
Rheumatology (Oxford); 2022 Mar; 61(3):e64-e66. PubMed ID: 34647989
[No Abstract] [Full Text] [Related]
9. Successful treatment of joint and fascial chronic graft-versus-host disease with baricitinib.
Shimizu M; Shimbo A; Takagi M; Eguchi K; Ishimura M; Sugita J; Morio T; Kanegane H
Rheumatology (Oxford); 2021 Dec; 61(1):e1-e3. PubMed ID: 34302457
[No Abstract] [Full Text] [Related]
10. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.
Nousari Y; Wu BC; Valenzuela G
Clin Exp Dermatol; 2021 Oct; 46(7):1330-1332. PubMed ID: 33914946
[No Abstract] [Full Text] [Related]
11. Improvement of chronic nodular prurigo with baricitinib.
Pereira MP; Zeidler C; Ständer S
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e486-e488. PubMed ID: 35138657
[No Abstract] [Full Text] [Related]
12. Multicentric reticulohistiocytosis successfully treated with baricitinib.
Chen Y; Li J; Zhu Y
Eur J Dermatol; 2022 Jul; 32(4):539-540. PubMed ID: 36301761
[No Abstract] [Full Text] [Related]
13. Treatment of Severe Nail Lichen Planus With Baricitinib.
Pünchera J; Laffitte E
JAMA Dermatol; 2022 Jan; 158(1):107-108. PubMed ID: 34878494
[No Abstract] [Full Text] [Related]
14. Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis.
De Greef A; Ghislain PD; Baeck M
Eur J Dermatol; 2023 Dec; 33(6):707-709. PubMed ID: 38465563
[No Abstract] [Full Text] [Related]
15. Baricitinib in Alopecia Areata.
Messenger A; Harries M
N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
[No Abstract] [Full Text] [Related]
16. Complete response of actinic prurigo to oral baricitinib.
Gil-Lianes J; Luque-Luna M; Morgado-Carrasco D
J Dtsch Dermatol Ges; 2024 Jun; 22(6):837-838. PubMed ID: 38613522
[No Abstract] [Full Text] [Related]
17. Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment.
Valor-Méndez L; Hagen M; Kleyer A; Manger B; Schett G
RMD Open; 2020 Nov; 6(3):. PubMed ID: 33214327
[No Abstract] [Full Text] [Related]
18. Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients.
Moreno-Vílchez C; Bonfill-Ortí M; Bauer-Alonso A; Notario J; Figueras-Nart I
J Am Acad Dermatol; 2024 May; 90(5):1059-1061. PubMed ID: 38246562
[No Abstract] [Full Text] [Related]
19. Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
Rubin R
JAMA; 2022 Jun; 327(23):2281. PubMed ID: 35727290
[No Abstract] [Full Text] [Related]
20. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
